黄芩汤首载于《伤寒论》，由黄芩Scutellariae Radix、白芍Paeoniae Radix Alba、甘草Glycyrrhizae Radix et Rhizoma和大枣Jujubae Fructu 4味中药组成。黄芩汤组方精妙、效专力宏，传承千年，至今仍在临床应用中发挥重要作用，具有广阔的开发应用前景。国家针对古代经典名方的研究发布了一系列的支持政策，黄芩汤于2023年被收录于国家中医药管理局公布的《古代经典名方目录（第2批）》，该方的研发受到国家的大力支持。为深入探索黄芩汤的现代研究进展，推动经典名方的创新研发，对近年来黄芩汤的化学成分、药理作用、临床应用、制剂研究等进行全面分析，为黄芩汤及经典名方的现代研究提供科学依据。

Huangqin Decoction (黄芩汤, HQD) was first recorded in the Treatise on Typhoid Fever. It is composed of four kinds of traditional Chinese medicines: Huangqin (Scutellariae Radix), Baishao (Paeoniae Radix Alba), Gancao (Glycyrrhizae Radix et Rhizoma), Dazao (Jujubae Fructu). The prescription of HQD is exquisite and effective, which has been handed down for thousands of years and still plays an important role in clinical application. The Chinese government has issued a series of support policies for the study of ancient classical prescriptions. HQD was included in the Catalogue of Ancient Classical Prescriptions (second batch), published by the State Administration of Traditional Chinese Medicine publication in 2023, its research and development has obtained the strategic support of the country. To further explore the advancements in modern research on HQD and promote the innovation and development of classical prescriptions, this study comprehensively analyzes the chemical composition, pharmacological effects, clinical applications, and preparation research of HQD in recent years. This provides a solid scientific foundation for the modern study of HQD and classical prescriptions.

R285

四川省大学生创新创业训练计划（S202410633023）